NURL logo

Neural Therapeutics Inc. Stock Price

CNSX:NURL Community·CA$2.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NURL Share Price Performance

CA$0.015
-0.01 (-50.00%)
CA$0.015
-0.01 (-50.00%)
Price CA$0.015

NURL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk and overvalued.

4 Risks
0 Rewards

Neural Therapeutics Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$990.0k

Other Expenses

-CA$990.0k

Earnings

Last Reported Earnings
Oct 31, 2025
Next Reporting Earnings
n/a
-0.0059
0%
0%
74.2%
View Full Analysis

About NURL

Founded
2020
Employees
n/a
CEO
Ian Campbell
WebsiteView website
www.neuraltherapeutics.ca

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine. Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. Neural Therapeutics Inc. was founded in 2020 and is headquartered in Toronto, Canada.

Recent NURL News & Updates

Recent updates

No updates